drugset / Trial / NCT01515592

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

NCT01515592

Phase 1 Completed 24 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Japan. The aim of this trial is to assess the safety and tolerability of 20 µg/kg and 25 µg/kg liraglutide in healthy Japanese male subjects.

Timeline

Start
2006-01
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 15 ug/kg Subcutaneous
Subject Liraglutide Peptide 20 ug/kg Subcutaneous
Subject Liraglutide Peptide 25 ug/kg Subcutaneous